Researchers enrolled 39 people with biomarker-confirmed mild cognitive impairment tied to Alzheimer’s disease in a phase II ...

Stimulants and atomoxetine are the only effective interventions to reduce short-term adult ADHD symptoms, yet show limited evidence for long-term outcomes and quality of life improvements, according ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the ...

FDA approves generic forms of Strattera The generic forms of Strattera are the first to be approved by the FDA for the treatment of ADHD. The US Food and Drug Administration (FDA) has approved the ...

Please provide your email address to receive an email when new articles are posted on . Stimulants and atomoxetine had short-term benefits in adults with ADHD, but long-term efficacy remains ...

We both treat ADHD patients with medication, and we are used to drug company representatives trying to show us the “latest and greatest” pharmaceutical innovation for ADHD. Unfortunately as noted in ...

New ADHD medications come with higher price tags but not always better results. Here’s what actually matters when choosing the right treatment.